Back
Speaker illustration

Ms Emily Ghanbari

Berlin (Germany)

Presentations Articles

Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research

Event: ESC Congress 2025

Topic: Experimental Heart Failure

Session: Basic bombshells in heart failure

Access
Like
Thumbnail

Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study

Event: ESC Congress 2025

Topic: Pathophysiology and Mechanisms

Session: Biomarkers and prognosis in acute heart failure

Access
Like
Thumbnail

Aortic regurgitation: links to declining hepatic-renal function, WWP-2 and IL-6 by genetic data

Event: ESC Congress 2025

Topic: Prevention

Session: Aortic regurgitation

Access
Like
Thumbnail

Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure

Event: ESC Congress 2024

Topic: Ventricular Remodelling

Session: Obesity and heart failure: what's new?

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources